
    
      This study was designed to improve smell disorders after corona infection that is very
      anxious for all patients.

      Inclusion criteria were loss of smell, post covid-19 infection, age from 18 to 70 years and
      accept sharing and follow up.

      The application of dosage form by ENT specialist at otorhinolaryngology clinic at Minia
      University hospital. Dose was 100iu of insulin 3 times weekly for 4 weeks. The new dosage
      form with insulin was compared with a placebo to ensure statistical improvement.

      The tests were performed in each visit. Primary outcome was the improvement of smell sensors
      in those patients
    
  